The AGACNP is beginning medical management of a patient newly diagnosed with Type 2 DM.
1) The AGACNP is beginning medical management of a patient newly diagnosed with Type 2 DM. The patient
has a BMI of 39 and has been unsuccessful in making significant diet and lifestyle changes over the last 6 months. Other than her weight, her physical examination is essentially within normal limits. Her HgbA1C is 9.5%. A basic metabolic panel is within normal limits. The medication of choice to begin therapy will be
a) A sulfonylurea
b) A meglitinide
c) A bigunaide
d) An incretin mimetic